Trials / Completed
CompletedNCT01092767
Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury
Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System for the Endovascular Treatment of Blunt Thoracic Aortic Injuries (RESCUE)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if the Valiant stent graft is safe and effective in treating patients who have a blunt thoracic aortic injury (BTAI). BTAI is when the aorta has been injured due to traumatic force to the chest area. It is commonly caused by motor vehicle accidents. In most cases it is life threatening and the standard treatment is surgery. Many times when a person has a BTAI they also have other injuries that can affect the results of the surgery. Since stent grafting has been an effective way to treat other aortic conditions such as aneurysms (bulge in aorta wall), it is believed that the Valiant stent graft would be effective in treating BTAI. A stent graft is a woven polyester tube (graft) supported by a metal frame of strong but flexible nitinol (type of metal) springs (stent) that is placed in the aorta to help seal the injury and keep it from bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Valiant Thoracic Stent Graft with the Captivia Delivery System | All subjects will be implanted with this device |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-04-01
- Completion
- 2017-05-01
- First posted
- 2010-03-25
- Last updated
- 2021-10-29
- Results posted
- 2014-03-28
Locations
25 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01092767. Inclusion in this directory is not an endorsement.